By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Vermillion climbed as much as 23 percent on Nasdaq by early Friday afternoon, following the announcement that diagnostic industry veteran Bruce Huebner had been appointed to the molecular diagnostic company's board of directors.

In addition to being a director, Huebner is expected to lead a special committee to evaluate the current sales and marketing strategy of Vermillion's OVA1 test for ovarian cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.